Hedge Fund - Biotechnology Value Fund / BVF Inc
Moonlake Immunotherapeutics (MLTX)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2024 - Q4 (2024-12-31) | $1,069,532,029 | 36.24% | 19,751,284 | $51.06 |
| 2 | 2024 - Q3 (2024-09-30) | $1,096,699,739 | 32.08% | 21,751,284 | $46.86 |
| 3 | 2024 - Q2 (2024-06-30) | $956,403,957 | 26.8% | 21,751,284 | $42.36 |
| 4 | 2024 - Q1 (2024-03-31) | $1,092,566,995 | 30.03% | 21,751,284 | $54.24 |
| 5 | 2023 - Q4 (2023-12-31) | $1,313,560,041 | 32.87% | 21,751,284 | $51.54 |
| 6 | 2023 - Q3 (2023-09-30) | $1,239,823,188 | 33.43% | 21,751,284 | $55.21 |
| 7 | 2023 - Q2 (2023-06-30) | $1,109,315,484 | 30.91% | 21,751,284 | $26.91 |
| 8 | 2023 - Q1 (2023-03-31) | $465,259,965 | 17% | 21,751,284 | $16.81 |
| 9 | 2022 - Q4 (2022-12-31) | $228,388,482 | 9.63% | 21,751,284 | $8.89 |
| 10 | 2022 - Q3 (2022-09-30) | $173,140,000 | 7.15% | 21,751,284 | $7.04 |
| 11 | 2022 - Q2 (2022-06-30) | $114,194,000 | 5.51% | 21,751,284 | $6.29 |
The displayed share prices are average quarterly stock market prices.